FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2206351610> ?p ?o ?g. }

• W2206351610 endingPage "537" @default.
• W2206351610 startingPage "523" @default.
• W2206351610 abstract "Nicotinamide (vitamin B3) was the first drug selected for cross-model testing by the Operation Brain Trauma Therapy (OBTT) consortium based on a compelling record of positive results in pre-clinical models of traumatic brain injury (TBI). Adult male Sprague-Dawley rats were exposed to either moderate fluid percussion injury (FPI), controlled cortical impact injury (CCI), or penetrating ballistic-like brain injury (PBBI). Nicotinamide (50 or 500 mg/kg) was delivered intravenously at 15 min and 24 h after injury with subsequent behavioral, biomarker, and histopathological outcome assessments. There was an intermediate effect on balance beam performance with the high (500 mg/kg) dose in the CCI model, but no significant therapeutic benefit was detected on any other motor task across the OBTT TBI models. There was an intermediate benefit on working memory with the high dose in the FPI model. A negative effect of the low (50 mg/kg) dose, however, was observed on cognitive outcome in the CCI model, and no cognitive improvement was observed in the PBBI model. Lesion volume analysis showed no treatment effects after either FPI or PBBI, but the high dose of nicotinamide resulted in significant tissue sparing in the CCI model. Biomarker assessments included measurements of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase-1 (UCH-L1) in blood at 4 or 24 h after injury. Negative effects (both doses) were detected on biomarker levels of GFAP after FPI and on biomarker levels of UCH-L1 after PBBI. The high dose of nicotinamide, however, reduced GFAP levels after both PBBI and CCI. Overall, our results showed a surprising lack of benefit from the low dose nicotinamide. In contrast, and partly in keeping with the literature, some benefit was achieved with the high dose. The marginal benefits achieved with nicotinamide, however, which appeared sporadically across the TBI models, has reduced enthusiasm for further investigation by the OBTT Consortium." @default.
• W2206351610 created "2016-06-24" @default.
• W2206351610 creator A5006282421 @default.
• W2206351610 creator A5012048939 @default.
• W2206351610 creator A5018477607 @default.
• W2206351610 creator A5023360077 @default.
• W2206351610 creator A5055437280 @default.
• W2206351610 creator A5057601283 @default.
• W2206351610 creator A5059902188 @default.
• W2206351610 creator A5076799832 @default.
• W2206351610 creator A5080778824 @default.
• W2206351610 creator A5082582879 @default.
• W2206351610 creator A5086289347 @default.
• W2206351610 creator A5090383944 @default.
• W2206351610 date "2016-03-15" @default.
• W2206351610 modified "2023-10-12" @default.
• W2206351610 title "Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy" @default.
• W2206351610 cites W1892211249 @default.
• W2206351610 cites W1950821376 @default.
• W2206351610 cites W1967560395 @default.
• W2206351610 cites W1968420682 @default.
• W2206351610 cites W1968991405 @default.
• W2206351610 cites W1983080331 @default.
• W2206351610 cites W1991731067 @default.
• W2206351610 cites W2000047585 @default.
• W2206351610 cites W2002235277 @default.
• W2206351610 cites W2024837368 @default.
• W2206351610 cites W2026134783 @default.
• W2206351610 cites W2028406208 @default.
• W2206351610 cites W2030350648 @default.
• W2206351610 cites W2031440032 @default.
• W2206351610 cites W2033297074 @default.
• W2206351610 cites W2037595610 @default.
• W2206351610 cites W2039137711 @default.
• W2206351610 cites W2042203151 @default.
• W2206351610 cites W2044443383 @default.
• W2206351610 cites W2053734785 @default.
• W2206351610 cites W2054047969 @default.
• W2206351610 cites W2054630513 @default.
• W2206351610 cites W2058432213 @default.
• W2206351610 cites W2067629356 @default.
• W2206351610 cites W2078345627 @default.
• W2206351610 cites W2078484961 @default.
• W2206351610 cites W2079624058 @default.
• W2206351610 cites W2080069940 @default.
• W2206351610 cites W2084682411 @default.
• W2206351610 cites W2090060778 @default.
• W2206351610 cites W2096268267 @default.
• W2206351610 cites W2099972916 @default.
• W2206351610 cites W2125683177 @default.
• W2206351610 cites W2138948255 @default.
• W2206351610 cites W2147783395 @default.
• W2206351610 cites W2158030857 @default.
• W2206351610 cites W2172592752 @default.
• W2206351610 cites W2174745877 @default.
• W2206351610 cites W2297621391 @default.
• W2206351610 cites W2298601289 @default.
• W2206351610 cites W2301016453 @default.
• W2206351610 cites W935842463 @default.
• W2206351610 doi "https://doi.org/10.1089/neu.2015.4115" @default.
• W2206351610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8418525" @default.
• W2206351610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33203303" @default.
• W2206351610 hasPublicationYear "2016" @default.
• W2206351610 type Work @default.
• W2206351610 sameAs 2206351610 @default.
• W2206351610 citedByCount "59" @default.
• W2206351610 countsByYear W22063516102016 @default.
• W2206351610 countsByYear W22063516102017 @default.
• W2206351610 countsByYear W22063516102018 @default.
• W2206351610 countsByYear W22063516102019 @default.
• W2206351610 countsByYear W22063516102020 @default.
• W2206351610 countsByYear W22063516102021 @default.
• W2206351610 countsByYear W22063516102022 @default.
• W2206351610 countsByYear W22063516102023 @default.
• W2206351610 crossrefType "journal-article" @default.
• W2206351610 hasAuthorship W2206351610A5006282421 @default.
• W2206351610 hasAuthorship W2206351610A5012048939 @default.
• W2206351610 hasAuthorship W2206351610A5018477607 @default.
• W2206351610 hasAuthorship W2206351610A5023360077 @default.
• W2206351610 hasAuthorship W2206351610A5055437280 @default.
• W2206351610 hasAuthorship W2206351610A5057601283 @default.
• W2206351610 hasAuthorship W2206351610A5059902188 @default.
• W2206351610 hasAuthorship W2206351610A5076799832 @default.
• W2206351610 hasAuthorship W2206351610A5080778824 @default.
• W2206351610 hasAuthorship W2206351610A5082582879 @default.
• W2206351610 hasAuthorship W2206351610A5086289347 @default.
• W2206351610 hasAuthorship W2206351610A5090383944 @default.
• W2206351610 hasConcept C118552586 @default.
• W2206351610 hasConcept C126322002 @default.
• W2206351610 hasConcept C142724271 @default.
• W2206351610 hasConcept C181199279 @default.
• W2206351610 hasConcept C204232928 @default.
• W2206351610 hasConcept C2779728014 @default.
• W2206351610 hasConcept C2780495277 @default.
• W2206351610 hasConcept C2781017439 @default.
• W2206351610 hasConcept C2781156865 @default.
• W2206351610 hasConcept C2781197716 @default.
• W2206351610 hasConcept C42219234 @default.

• next